Register to View Using Natural Language Processing to Identify Adverse Drug Events of Angiotensin Converting Enzyme Inhibitors – OMNY Health Poster

On June 9-11, 2021, this poster was on display at the virtual International Forum on Quality and Safety in Healthcare EUROPE. 

What is the Objective of this Poster?

• Validate an end-to-end adverse drug event (ADE) detection system from the licensed software package Spark NLP for Healthcare (John Snow Labs, Inc)
• Assess results against known ADEs of angiotensin converting enzyme inhibitors (ACE-I; a drug class for treatment of renal failure, hypertension, and heart disease)